Immunovia AB (publ) (STO:IMMNOV)
0.6350
-0.0050 (-0.78%)
Sep 12, 2025, 5:29 PM CET
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 194.36 million as of September 12, 2025. Its market cap has increased by 349.87% in one year.
Market Cap
194.36M
Enterprise Value
165.56M
Revenue
919.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.64
Market Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 194.36M, a decrease of -54.21%. That is a compound annual growth rate of -7.67%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 11, 2025 | 195.89M | 111.41% |
Dec 30, 2024 | 92.66M | 15.47% |
Dec 29, 2023 | 80.25M | -86.52% |
Dec 30, 2022 | 595.21M | -64.93% |
Dec 30, 2021 | 1.70B | -37.08% |
Dec 30, 2020 | 2.70B | -23.58% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Dec 1, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Swedish Orphan Biovitrum AB | 96.11B |
Sectra AB | 63.00B |
Getinge AB | 57.82B |
Camurus AB | 43.58B |
Medicover AB | 40.92B |
Asker Healthcare Group AB | 35.20B |
BioArctic AB | 25.26B |
AddLife AB | 22.19B |